Table 1

Baseline characteristics according to cytogenetic abnormalities

Standard-risk (n = 188)High-risk* (n = 44)P
Age, y (range) 72 (65-85) 72 (66-83) NS 
Hemoglobin, g/dL, mean 10.8 9.6 NS 
Calcium, mg/dL, mean 9.6 9.5 NS 
Creatinine, mg/dL, mean 1.02 1.0 NS 
B2-microglobulin, mg/L, mean 3.8 5.2 NS 
PCs BM infiltration, %, mean 38 44 NS 
S-phase of PCs, % 1.5 1.5 NS 
ISS stage, %    
    I 28 16  
    II 42 41 NS 
    III 30 43  
Induction regimen, %    
    VMP/VTP 49/51 50/50 NS 
Maintenance regimen, %    
    VT/VP 51/49 54/46 NS 
Standard-risk (n = 188)High-risk* (n = 44)P
Age, y (range) 72 (65-85) 72 (66-83) NS 
Hemoglobin, g/dL, mean 10.8 9.6 NS 
Calcium, mg/dL, mean 9.6 9.5 NS 
Creatinine, mg/dL, mean 1.02 1.0 NS 
B2-microglobulin, mg/L, mean 3.8 5.2 NS 
PCs BM infiltration, %, mean 38 44 NS 
S-phase of PCs, % 1.5 1.5 NS 
ISS stage, %    
    I 28 16  
    II 42 41 NS 
    III 30 43  
Induction regimen, %    
    VMP/VTP 49/51 50/50 NS 
Maintenance regimen, %    
    VT/VP 51/49 54/46 NS 

ISS indicates International Staging System; and PCs, plasma cells.

*

Forty-four of these 232 patients qualified as high-risk (19%); 17 of them (7%) had t(4;14) ± del(13q), 21 patients (9%) had del(17p) ± del(13q), in 3 cases (1%) t(4;14) and del(17p) coexisted, and 3 additional patients (1%) had t(14;16). Only 1 patient had t(4;14) as single CA.

or Create an Account

Close Modal
Close Modal